Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.9%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check68 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a Phase 1 study comparing subcutaneous and intravenous formulations of CT-P13 for treating Crohn's Disease and Ulcerative Colitis. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference15%
Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.